West Pharmaceutical Services, Inc. (WST) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for West Pharmaceutical Services, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 40.29x | 48.53x | 44.09x | 29.89x | 52.73x | 60.48x |
| P/B Ratio | 6.26x | 8.91x | 9.08x | 6.52x | 14.94x | 11.29x |
| P/S Ratio | 6.47x | 8.27x | 8.87x | 6.07x | 12.33x | 9.75x |
| Profitability | ||||||
| Gross Margin | 35.9% | 34.6% | 38.4% | 39.5% | 41.5% | 35.8% |
| Operating Margin | 20.1% | 20.6% | 24.1% | 26.5% | 26.8% | 19.5% |
| Net Margin | 16.1% | 17.0% | 20.1% | 20.3% | 23.4% | 16.1% |
| EBITDA Margin | 23.5% | 25.7% | 28.6% | 28.0% | 31.1% | 24.2% |
| Liquidity | ||||||
| Current Ratio | 3.02x | 2.79x | 2.88x | 3.70x | 2.93x | 2.73x |
| Quick Ratio | 2.34x | 2.11x | 2.24x | 2.90x | 2.30x | 2.09x |
| Leverage | ||||||
| Debt/Equity | 0.13x | 0.11x | 0.11x | 0.12x | 0.14x | 0.18x |
YoY = year-over-year change. Source: FMP..